Human neutrophils express the high-affinity receptor for immunoglobulin E (Fc epsilon RI): role in asthma

A S Gounni1, B Lamkhioued, L Koussih

  • 1Meakins Christie Laboratories, McGill University, Montreal, Quebec, Canada. Abdel@meakins.lan.mcgill.ca

Insights

Polymorphonuclear neutrophils (PMNs) express the high-affinity IgE receptor Fc epsilon RI, particularly in asthma. This finding suggests PMNs may contribute to allergic inflammation via IgE-dependent activation.

Area of Science:

  • Immunology
  • Allergy Research
  • Cell Biology

Background:

  • Polymorphonuclear neutrophils (PMNs) are key immune cells involved in host defense and inflammation.
  • IgE receptors, including Fc epsilon RI, are crucial in allergic diseases.
  • Previous studies identified other IgE receptors on PMNs, but Fc epsilon RI expression was unconfirmed.

Purpose of the Study:

  • To investigate the expression and function of the high-affinity IgE receptor, Fc epsilon RI, on PMNs.
  • To determine if Fc epsilon RI on PMNs plays a role in allergic inflammation.

Main Methods:

  • Analysis of Fc epsilon RI alpha chain mRNA and cell surface expression on PMNs from asthmatic subjects.
  • Blocking assays using human IgE Fc fragment and anti-Fc epsilon RI alpha chain antibody (mAb15--1).
  • Immunoreactivity assessment for Fc epsilon RI alpha and beta chains in peripheral blood and bronchoalveolar lavage (BAL) PMNs.

Main Results:

  • Fc epsilon RI alpha chain mRNA and cell surface expression were detected on PMNs from asthmatic individuals.
  • IgE binding to PMNs was primarily mediated by Fc epsilon RI.
  • Intracellular Fc epsilon RI alpha and beta chains were found in asthmatic PMNs.
  • Fc epsilon RI engagement stimulated IL-8 release from PMNs.

Conclusions:

  • PMNs express the Fc epsilon RI receptor.
  • This expression suggests a potential role for PMNs in allergic inflammation through IgE-dependent mechanisms.
  • Further research into PMN activation pathways in allergy is warranted.

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Antibody Structure01:10

Antibody Structure

Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Allergic Reactions02:06

Allergic Reactions

Overview